GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Common Stock

Cannara Biotech (TSXV:LOVE) Common Stock : C$88.52 Mil (As of Aug. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Common Stock?

Cannara Biotech's quarterly common stock stayed the same from Feb. 2024 (C$88.52 Mil) to May. 2024 (C$88.52 Mil) and stayed the same from May. 2024 (C$88.52 Mil) to Aug. 2024 (C$88.52 Mil).

Cannara Biotech's annual common stock increased from Aug. 2022 (C$83.30 Mil) to Aug. 2023 (C$88.80 Mil) but then declined from Aug. 2023 (C$88.80 Mil) to Aug. 2024 (C$88.52 Mil).


Cannara Biotech Common Stock Historical Data

The historical data trend for Cannara Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Common Stock Chart

Cannara Biotech Annual Data
Trend Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Common Stock
Get a 7-Day Free Trial 58.36 83.21 83.30 88.80 88.52

Cannara Biotech Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.80 88.53 88.52 88.52 88.52

Cannara Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Cannara Biotech Business Description

Traded in Other Exchanges
Address
1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
Executives
Nicholas Sosiak Senior Officer
Olymbec Investments Inc. 10% Security Holder
Derek Elan Stern Director
Donald John Olds Director
Scott Carroll Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Zohar Krivorot Director, Senior Officer
Brian Sherman Senior Officer
Avi Krivorot Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Lennie Ryer Senior Officer
Jack M. Kay Director
Donal Carroll Director or Senior Officer of 10% Security Holder